NSAID, Paracetamol

Small molecule

AAin Shams University

NSAID, Paracetamol is one of 5 small molecule programs targeting Pneumothorax. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumothoraxActive, not recruiting

PneumothoraxPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Pneumothorax

#DrugCompanyPhaseTrials

Minocin

Paracetamol

1 3

Platelet Rich Plasma

ZZagazig University

Phase 1

1 4

Achromycin V

WWyeth-Lederle Vaccines

Preclinical

1 5

NSAID, Paracetamol

AAin Shams University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pneumothorax1 trial

Does Non-Steroidal Anti-inflammatory Drugs Decrease the Quality of Pleurodesis After Mechanical Pleural Abrasion/Pleurectomy for Treatment of Pneumothorax?

Recruiting·—·Phase 1/2·NCT06467318·116 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for NSAID, Paracetamol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — NSAID, Paracetamol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for NSAID, Paracetamol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ain Shams University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: AAin Shams University

NSAID, Paracetamol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pneumothorax1 trial

References

Drug Info

Quick Facts

Related News